MANUEL
PRAGA TERENTE
Profesor emérito
Seoul National University Hospital
Seúl, Corea del SurPublicaciones en colaboración con investigadores/as de Seoul National University Hospital (2)
2021
-
Correction to: Efficacy and safety of the long-acting C5 inhibitor ravulizumab in patients with atypical hemolytic uremic syndrome triggered by pregnancy: a subgroup analysis (BMC Nephrology, (2021), 22, 1, (5), 10.1186/s12882-020-02190-0)
BMC Nephrology
-
Efficacy and safety of the long-acting C5 inhibitor ravulizumab in patients with atypical hemolytic uremic syndrome triggered by pregnancy: a subgroup analysis
BMC Nephrology, Vol. 22, Núm. 1